Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：Chase

Clinical trial NCT07555678 · RECRUITING

Trial details

NCT number: NCT07555678
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anal Squamous Cell Cancer

Start date: 2024-04-01
Primary completion: 2027-12-31
Enrollment: 241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.